392292-89-6

Upstream product

• 160744-60-5 4-((tert-butyldimethylsilyloxy)methyl)benzaldehyde 
• 18162-48-6 tert-butyldimethylsilyl chloride 
• 874-89-5 4-Cyanobenzyl alcohol 

Downstream Products

• 1613166-39-4 3-[4-(tert-butyldimethylsilanyloxymethyl)phenyl]isoxazole-5-carboxylic acid amide 
• 1613166-40-7 3-(4-hydroxymethylphenyl)isoxazole-5-carboxylic acid amide 
• 1613166-47-4 C₁₄H₂₂ClNO₂Si 
• 1613166-41-8 3-(4-formylphenyl)isoxazole-5-carboxylic acid amide 
• 1613166-17-8 3-[4-(2,3-dihydroindol-1-ylmethyl)phenyl]isoxazole-5-carboxylic acid amide 
• 1613166-18-9 3-[4-(1,3-dihydroisoindol-2-ylmethyl)phenyl]isoxazole-5-carboxylic acid amide 
• 1613166-24-7 3-[4-(3,4-dihydro-2H-quinolin-1-ylmethyl)phenyl]isoxazole-5-carboxylic acid amide 
• 1613166-25-8 3-[4-(2-methyl-2,3-dihydroindol-1-ylmethyl)phenyl]isoxazole-5-carboxylic acid amide 

Relevant academic research and scientific papers

SUBSTITUTED ISOXAZOLE AMIDE COMPOUNDS AS INHIBITORS OF STEAROYL-COA DESATURASE 1 (SCD1)

The invention is concerned with a compound of formula (I) and pharmaceutically acceptable salts thereof. In addition, the present invention relates to methods of manufacturing and using the compound of formula (I) as well as pharmaceutical compositions containing such compounds. The compound of formula (I) are SCD1 inhibitors and may be useful in treating cancer.